Neuren Pharmaceuticals Limited
ASX:NEU
$ 21.09
$0.00 (0.00%)
$ 21.09
$0.00 (0.00%)
End-of-day quote: 05/18/2024

Neuren Pharmaceuticals financials at a glance

The revenue of Neuren Pharmaceuticals is reported as 0.23193 billion Dollars in the fiscal year 2023. The earnings were 1.2 Dollars per share in 2023, which was 100 higher than 2022. And about 0.17969 billion Dollars are reported as free cash flow in the financials of Neuren Pharmaceuticals 2023. No dividends were paid to the shareholders of the Neuren Pharmaceuticals stock ASX:NEU in the financial year 2023.

$231.93M
Revenue
$1.20
Earnings Per Share
88.47%
Gross Margin %
$175.35M
Free Cash Flow
Revenue
231.93
Earnings Per Share
1.20
Gross Margin %
88.47
Free Cash Flow
175.35

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Rev. Revenue N/A $231.93M $17.03M $3.64M $0.96M $1.02M $15.17M $0.63M $1.31M $1.67M $2.93M $5.24M
GM % Gross Margin % 75.50% 88.47% 17.55% -,197.65% 0.00% 0.00% 56.39% 0.00% 0.00% 0.00% -,241.73% -80.50%
OM Operating Margin 69.88% 85.90% -4.75% -,257.52% 0.00% 0.00% 41.57% 0.00% 0.00% 0.00% 0.00% -,138.01%
EPS Earnings Per Share $0.42 $1.20 $0.00 $-0.07 $-0.09 $-0.11 $0.07 $-0.01 $-0.12 $-0.16 $-0.10 $-0.13
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0.00% 0 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 127.27M 125.97M 125.97M 114.61M 100.17M 100.17M 97.34M 92.1M 88.35M 81.26M 75.63M
OCF Operating Cash Flow N/A $179.73M $3.60M $-9.97M $-8.08M $-11.72M $6.41M $-5.59M $-12.38M $-12.73M $-6.41M $-7.76M
FCF Free Cash Flow N/A $175.35M $3.58M $-9.98M $-8.08M $-11.73M $6.41M $-5.59M $-12.39M $-12.73M $-6.44M $-7.78M
FCFS Free Cash Flow Per Share $0.43 $1.45 $0.03 $-0.08 $-0.08 $-0.12 $0.06 $-0.06 $-0.15 $-0.15 $-0.08 $-0.11